Project Number 5R21NS064334-02 Agency/Funding Organization NINDS Funding Year 2010 View Full Project Details for IN VIVO EFFICACY OF NEW NEUROPROTECTIVE DRUGS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator SCHUBERT, DAVID R Principal Investigator First Name PAMELA Principal Investigator Last Name MAHER Awardee Organization SALK INSTITUTE FOR BIOLOGICAL STUDIES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-232: NINDS EXPLORATORY/DEVELOPMENTAL PROJECTS IN TRANSLATIONAL RESEARCH (R21) FY Overall Cost $234,383 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CORRIVEAU, RODERICK A Related Resources Repository [AlzPED] A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease
